Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.43 |
| ▸ | ADH1B | P00325 | 2/20 | 0.39 |
| ▸ | ADH1C | P00326 | 2/20 | 0.39 |
| ▸ | ADH1A | P07327 | 2/20 | 0.39 |
| ▸ | ADH4 | P08319 | 2/20 | 0.39 |
| ▸ | ADH7 | P40394 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TOP1 | P11387 | 2/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11053276 | 1.00 | TSHR (0.48) | TSHRFAAHTRPV1ADH1BADH1C | |
| SCHEMBL5680694 | 1.00 | TSHR (0.48) | TSHRFAAHTRPV1ADH1BADH1C | |
| SCHEMBL152136 | 0.90 | — | — | |
| SCHEMBL1653708 | 0.79 | — | — | |
| SCHEMBL5552653 | 0.79 | TSHR (0.58) | TSHRFAAHTRPV1ADH1BADH1C | |
| SCHEMBL8602710 | 0.76 | TSHR (0.48) | TSHRFAAHTHRB | |
| SCHEMBL11041293 | 0.76 | TSHR (0.57) | TSHREPHX1THRB | |
| SCHEMBL10317806 | 0.76 | TSHR (0.57) | TSHREPHX1THRB | |
| SCHEMBL6234379 | 0.76 | TSHR (0.57) | TSHREPHX1THRB | |
| SCHEMBL152301 | 0.76 | TSHR (0.57) | TSHREPHX1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3969490-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS | BRIDGESTONE CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12479935-B2 | Polymerization processes for the production of cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2025-11-25 | — | — | US | disclosed |
| US-12410263-B2 | Modified high-Cis polybutadiene polymer, related methods and rubber compositions | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12371516-B2 | Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-12264232-B2 | Modified high-cis polybutadiene polymer, related methods and tire components | BRIDGESTONE CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| US-20250066516-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| EP-4495146-A2 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | Bridgestone Americas Tire Operations, LLC (US) | 2025-01-22 | — | — | EP | disclosed |
| US-12168705-B2 | Modified high cis polydiene polymer, related methods and rubber compositions | BRIDGESTONE CORPORATION (JP) | 2024-12-17 | — | — | US | disclosed |
| EP-4457250-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | Bridgestone Corporation (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-1242482-A1 | IRON-BASED CATALYST FOR PRODUCING BINARY CIS-1,4-/1,2-POLYBUTADIENE | Bridgestone Corporation (JP) | 2002-09-25 | — | — | EP | disclosed |
| WO-2002068484-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | BRIDGESTONE CORPORATION (JP) | 2002-09-06 | — | — | WO | disclosed |
| WO-2002066525-A1 | CHROMIUM-BASED CATALYST COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2002-08-29 | — | — | WO | disclosed |
| US-20020115558-A1 | CHROMIUM-BASED CATALYST COMPOSITION FOR PRODUCING CONJUGATED DIENE POLYMERS | BRIDGESTONE CORP. | 2002-08-22 | — | — | US | disclosed |
| US-20020037967-A1 | Process for producing blends of syndiotactic 1,2-polybutadiene and rubbery elastomers with a chromium-based catalyst system | BRIDGESTONE CORPORATION (JP) | 2002-03-28 | — | — | US | disclosed |
| US-6320004-B1 | FORMED BY COMBINING (A) A IRON-CONTAINING COMPOUND; (B) AN ORGANOMAGNESIUM COMPOUND; AND (C) A SILYL PHOSPHONATE; POLYMERIZING CONJUGATED DIENE MONOMERS | BRIDGESTONE CORPORATION (JP) | 2001-11-20 | — | — | US | disclosed |
| WO-2001079309-A2 | USE OF A Cr- OR Mo-BASED CATALYST SYSTEM TO PRODUCE BLENDS OF SYNDIOTACTIC 1,2-POLYBUTADIENE AND RUBBERY ELASTOMERS | BRIDGESTONE CORPORATION (JP) | 2001-10-25 | — | — | WO | disclosed |
| US-6291591-B1 | PROVIDING MIXTURE OF RUBBER CEMENT AND 1,3-BUTADIENE; POLYMERIZING 1,3-BUTADIENE BY USING A CATALYST WHICH IS COMBINATION OF OR THE REACTION PRODUCT OF CHROMIUM COMPOUND, HYDROGEN PHOSPHITE, ORGANOMAGNESIUM COMPOUND | BRIDGESTONE CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| WO-2001049755-A1 | IRON-BASED CATALYST FOR PRODUCING BINARY Cis-1,4-/1,2-POLYBUTADIENE | BRIDGESTONE CORPORATION (JP) | 2001-07-12 | — | — | WO | disclosed |
| US-6160063-A | Iron-based catalyst for producing binary cis-1,4-/1,2-polybutadiene | BRIDGESTONE CORPORATION (JP) | 2000-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | MALT1, INO80C, RTCB | TSHR 1694/4885FAAH 2217/4885TRPV1 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.